34466238|t|Seizure and delirium secondary to carboplatin and pantoprazole therapy-induced hypomagnesemia in a cancer patient.
34466238|a|Active surveillance and treatment of hypomagnesemia along with strict avoidance of concurrent offending agents is essential to prevent its grave clinical consequences among patients on carboplatin therapy.
34466238	0	7	Seizure	Disease	MESH:D012640
34466238	12	20	delirium	Disease	MESH:D003693
34466238	34	45	carboplatin	Chemical	MESH:D016190
34466238	50	62	pantoprazole	Chemical	MESH:D000077402
34466238	79	93	hypomagnesemia	Disease	OMIM:613882
34466238	99	105	cancer	Disease	MESH:D009369
34466238	106	113	patient	Species	9606
34466238	152	166	hypomagnesemia	Disease	OMIM:613882
34466238	288	296	patients	Species	9606
34466238	300	311	carboplatin	Chemical	MESH:D016190
34466238	Negative_Correlation	MESH:D016190	MESH:D009369
34466238	Association	MESH:D000077402	MESH:D009369
34466238	Cotreatment	MESH:D000077402	MESH:D016190
34466238	Positive_Correlation	MESH:D016190	MESH:D003693
34466238	Positive_Correlation	MESH:D000077402	MESH:D003693
34466238	Positive_Correlation	MESH:D000077402	OMIM:613882
34466238	Positive_Correlation	MESH:D016190	MESH:D012640
34466238	Positive_Correlation	MESH:D016190	OMIM:613882
34466238	Positive_Correlation	MESH:D000077402	MESH:D012640

